Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer

Author:

Han Baohui1,Li Kai2,Wang Qiming34,Zhang Li5,Shi Jianhua6,Wang Zhehai7,Cheng Ying8,He Jianxing9,Shi Yuankai10,Zhao Yizhuo1,Yu Hao11,Zhao Yang11,Chen Weiqiang12,Luo Yi13,Wu Lin13,Wang Xiuwen14,Pirker Robert15,Nan Kejun16,Jin Faguang17,Dong Jian18,Li Baolan19,Sun Yan10

Affiliation:

1. Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China

2. Department of Thoracic Oncology, Tianjin Medical University Cancer Hospital, Tianjin, China

3. Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China

4. Henan Cancer Hospital, Zhengzhou, China

5. Department of Respiratory Diseases, Peking Union Medical College Hospital, Beijing, China

6. Department of Oncology, Linyi Cancer Hospital, Linyi, China

7. Department of Internal Medicine-Oncology, Shandong Cancer Hospital, Jinan, China

8. Department of Thoracic Oncology, Jilin Cancer Hospital, Changchun, China

9. Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

10. Department of Medical Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China

11. Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China

12. Department of Pulmonary Medicine, Lanzhou Military General Hospital, Lanzhou, China

13. Department of Medical Oncology, Hunan Cancer Hospital, Changsha, China

14. Department of Chemotherapy, Qilu Hospital of Shandong University, Jinan, China

15. Department of Medicine I, Medical University of Vienna, Vienna, Austria

16. Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an, China

17. Department of Respiratory Diseases, Tang Du Hospital, Xi’an, China

18. First Department of Medical Oncology, Yunnan Cancer Hospital, Kunming, China

19. Department of General Medicine, Capital Medical University, Beijing Chest Hospital, Beijing, China

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Reference24 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.;Ferlay;Int J Cancer,2015

2. Cancer statistics in China, 2015.;Chen;CA Cancer J Clin,2016

3. Cancer treatment and survivorship statistics, 2016.;Miller;CA Cancer J Clin,2016

4. Advances in chemotherapy in advanced non-small-cell lung cancer.;Maione;Expert Opin Pharmacother,2010

5. Targeted therapy for non-small cell lung cancer: current standards and the promise of the future.;Chan;Transl Lung Cancer Res,2015

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3